HILZINGER KURT J
SEC CIK 1191504 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics, Inc. | Dir | 423.7K | $803.0K | — | 6 | 2022-02-22 | 2026-05-26 |
Most active insiders at OTLK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sukhtian Ghiath M. | Dir, 10% | $7.50M | — |
| 2 | HILZINGER KURT J | Dir | $176.5K | — |
| 3 | Sukhtian Faisal Ghiath | Dir | $150.0K | — |
| 4 | Haddadin Yezan Munther | Dir | $39.1K | — |
| 5 | THURMAN RANDY H | Dir | $2,145 | — |
| 6 | Jahr Robert Charles | CEO, Dir | — | — |
| 7 | KENYON LAWRENCE A | CFO, Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-27 15:15 | 2026-05-26 | OTLK | Outlook Therapeutics, Inc. | HILZINGER KURT J | Dir | P - Purchase | $0.4413 | +400.0K | 423.7K | +1,691% | +$176.5K | |
| M | 2022-10-05 | 2022-10-04+ | OTLK | Outlook Therapeutics, Inc. | HILZINGER KURT J | Dir | P - Purchase | $1.28 | +111.2K | 473.1K | +31% | +$142.5K |
| M | 2022-10-03 | 2022-09-29+ | OTLK | Outlook Therapeutics, Inc. | HILZINGER KURT J | Dir | P - Purchase | $1.24 | +88.8K | 286.9K | +45% | +$110.5K |
| 2022-03-03 | 2022-03-01 | OTLK | Outlook Therapeutics, Inc. | HILZINGER KURT J | Dir | P - Purchase | $1.69 | +27.7K | 273.1K | +11% | +$46.8K | |
| M | 2022-02-28 | 2022-02-24+ | OTLK | Outlook Therapeutics, Inc. | HILZINGER KURT J | Dir | P - Purchase | $1.48 | +47.2K | 245.4K | +24% | +$69.7K |
| M | 2022-02-23 | 2022-02-22+ | OTLK | Outlook Therapeutics, Inc. | HILZINGER KURT J | Dir | P - Purchase | $1.47 | +175.1K | 118.7K | New | +$257.0K |
Purchase Sale Sale after option exercise All abbreviations